Shopping Cart 0
Cart Subtotal
AED 0

GW Pharmaceuticals Plc (GWPH) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company's commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing products for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy syndrome, glioma, schizophrenia, autism among others. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc (GWPH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

GW Pharmaceuticals Plc, Medical Equipment, Deal Details 10

Private Equity 10

Mentor Capital Invests USD1 Million in GW Pharma 10

Equity Offering 11

GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 11

GW Pharma Raises USD317.4 Million in Public Offering of Shares 13

GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 15

GW Pharma Completes Public Offering Of American Depositary Shares For USD 101 Million 17

Acquisition 19

GW Pharma May Sell Itself 19

GW Pharmaceuticals Plc-Key Competitors 20

GW Pharmaceuticals Plc-Key Employees 21

GW Pharmaceuticals Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 23

May 08, 2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results 25

Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 26

May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 28

Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 30

Corporate Communications 31

Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 31

May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 32

Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director-UK 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

GW Pharmaceuticals Plc, Medical Equipment, Key Facts, 2017 2

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Deals By Market, 2012 to YTD 2018 8

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Mentor Capital Invests USD1 Million in GW Pharma 10

GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 11

GW Pharma Raises USD317.4 Million in Public Offering of Shares 13

GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 15

GW Pharma Completes Public Offering Of American Depositary Shares For USD 101 Million 17

GW Pharma May Sell Itself 19

GW Pharmaceuticals Plc, Key Competitors 20

GW Pharmaceuticals Plc, Key Employees 21

GW Pharmaceuticals Plc, Other Locations 22

GW Pharmaceuticals Plc, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

GW Pharmaceuticals Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company's commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing products for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy syndrome, glioma, schizophrenia, autism among others. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc (GWPH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

GW Pharmaceuticals Plc, Medical Equipment, Deal Details 10

Private Equity 10

Mentor Capital Invests USD1 Million in GW Pharma 10

Equity Offering 11

GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 11

GW Pharma Raises USD317.4 Million in Public Offering of Shares 13

GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 15

GW Pharma Completes Public Offering Of American Depositary Shares For USD 101 Million 17

Acquisition 19

GW Pharma May Sell Itself 19

GW Pharmaceuticals Plc-Key Competitors 20

GW Pharmaceuticals Plc-Key Employees 21

GW Pharmaceuticals Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 23

May 08, 2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results 25

Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 26

May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 28

Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 30

Corporate Communications 31

Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 31

May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 32

Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director-UK 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

GW Pharmaceuticals Plc, Medical Equipment, Key Facts, 2017 2

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

GW Pharmaceuticals Plc, Deals By Market, 2012 to YTD 2018 8

GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Mentor Capital Invests USD1 Million in GW Pharma 10

GW Pharma Raises USD345.2 Million in Public Offering of American Depositary Shares 11

GW Pharma Raises USD317.4 Million in Public Offering of Shares 13

GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 15

GW Pharma Completes Public Offering Of American Depositary Shares For USD 101 Million 17

GW Pharma May Sell Itself 19

GW Pharmaceuticals Plc, Key Competitors 20

GW Pharmaceuticals Plc, Key Employees 21

GW Pharmaceuticals Plc, Other Locations 22

GW Pharmaceuticals Plc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

GW Pharmaceuticals Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.